10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Archives : Old artciles

Wednesday, October 14, 2009

JMT Auto Ltd and Dolphin Medical Services Ltd:Future growth outlook and prospects

1)Scripscan:JMT Auto Ltd

Story:JMT Auto makes transmission components for automobiles and earthmovers. It supplies to clients such as Tata Motors, TELCON, Caterpillar and BEML.The company appears to have better growth prospects, as the user segment is on an uptrend in the country. Export opportunities too look promising. With steel prices stable operating margins can be expected to be stable in the near term. The company is on an expansion mode, which could help it capitalise on the growth opportunities.Prsent price looks attractive, given the company's growth prospects.A good hold.

2)Scripscan:Dolphin Medical Services Ltd

Story:Dolphin provides a range of diagnostic services, including ophthalmic laser care, at Vijayawada in Andhra Pradesh.The company has also set up diagnostic facilities at Mumbai and Hyderabad, apart from upgrading existing facilities at Vijayawada.Through its expansion, Dolphin intends to cash in on the positive demand environment that exists. While there is demand, we believe that Dolphin's ability to capitalise on it, given its constraints of lack of size, would be a key challenge.Success in such markets hinges on aggressively marketing services to members of the medical community to gain acceptance; markets in metro cities can be expected to be intensely competitive. Dolphin's lack of a marketing set-up would be a significant drawback in this regard.The other area that Dolphin intends to focus is the clinical trials space. While the intention is noteworthy, what Dolphin lacks is a headstart. Given the prevalence of a number of diseases, India has become one of the preferred destinations for conducting clinical trials. The diversity of the testing population has spawned not only Indian outfits, but has also led to foreign players such as Quintiles participating to take advantage of this opportunity. In the face of such competition, Dolphin's ability to engage and partner large multinationals, considering its small scale, will be put to the test.At 2-3rs one can hold the stock.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner